Skip to main content

Kresmion signals archive

57 cross-asset signals fired across commodity, crypto, equity, macro.

crypto (13)

  • highdex_thin_liquidityUSDC

    USDC/USDT has $188.2M volume but only $884K liquidity - thin market, slippage risk

  • highetf_flow_anomalyBTC

    BTC ETF inflow of $272M - institutional buying

  • highdex_price_crashUSDUC

    USDUC/SOL crashed -52.0% in 24h on pumpswap DEX

  • highetf_flow_anomalyETH

    ETH ETF inflow of $116M - institutional buying

  • highdex_thin_liquidityUSDC

    USDC/USDT has $199.3M volume but only $884K liquidity - thin market, slippage risk

  • highdex_price_crashUSDUC

    USDUC/SOL crashed -22.1% in 24h on pumpswap DEX

  • highdex_thin_liquidityUSDC

    USDC/USDT has $169.6M volume but only $884K liquidity - thin market, slippage risk

  • highetf_flow_anomalyBTC

    BTC ETF inflow of $251M - institutional buying

  • highdex_thin_liquidityUSDC

    USDC/USDT has $182.2M volume but only $884K liquidity - thin market, slippage risk

  • mediumdex_volume_liquidityETH

    ETH DEX volume/liquidity ratio elevated (0.57x) - strong on-chain trading activity

  • mediumdex_volume_liquiditySOL

    SOL DEX volume/liquidity ratio elevated (0.68x) - strong on-chain trading activity

  • mediumdex_volume_liquidityETH

    ETH DEX volume/liquidity ratio elevated (0.54x) - strong on-chain trading activity

  • mediumdex_volume_liquiditySOL

    SOL DEX volume/liquidity ratio elevated (0.78x) - strong on-chain trading activity

equity (36)

  • highFDA_APPROVALPFE

    FDA approves CLINDAMYCIN PHOSPHATE (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves CLEOCIN PEDIATRIC (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves CLEOCIN HYDROCHLORIDE (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves AZULFIDINE EN-TABS (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves PROCARDIA XL (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALMRK

    FDA approves drug (Merck) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves VUITY (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CELEXA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves DEPAKOTE ER (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves ESTRADIOL (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves FML FORTE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves MAVYRET (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves OXYTROL FOR WOMEN (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves RINVOQ (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves UBRELVY (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves ZEMPLAR (AbbVie) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • mediumtrend_spikeAWK

    American Water Works search volume spiked +100 pts - unusual interest

  • mediumtrend_spikeEFX

    Equifax search volume spiked +69 pts - unusual interest

  • mediumtrend_spikeGM

    General Motors search volume spiked +56 pts - unusual interest

  • mediumtrend_spikeGE

    GE Aerospace search volume spiked +53 pts - unusual interest

  • mediumtrend_spikeEVRG

    Evergy search volume spiked +49 pts - unusual interest

  • mediumtrend_spikeLNT

    Alliant Energy search volume spiked +62 pts - unusual interest

  • mediumrsi_crossAAPL

    AAPL RSI 71.1 - overbought (crossed above 70)

  • mediumtrend_spikeGM

    General Motors search volume spiked +44 pts - unusual interest

  • mediumEARNINGS_BEATSTX

    Beat consensus by 15.7% - EPS $4.1 vs $3.544 estimate

  • mediumEARNINGS_BEATSOLV

    Q1-2026: Beat consensus by 7.3% - EPS $1.48 vs $1.3788 estimate

  • mediumEARNINGS_BEATPTC

    Q2-2026: Beat consensus by 26.4% - EPS $2.69 vs $2.1278 estimate

  • mediumEARNINGS_BEATPODD

    Q1-2026: Beat consensus by 16.2% - EPS $1.42 vs $1.2221 estimate

  • mediumEARNINGS_BEATAPA

    Q1-2026: Beat consensus by 21.9% - EPS $1.38 vs $1.1325 estimate

  • mediumEARNINGS_BEATALB

    Q1-2026: Beat consensus by 174.8% - EPS $2.95 vs $1.0734 estimate

  • mediumtrend_spikeAMCR

    Amcor search volume spiked +69 pts - unusual interest

  • mediumtrend_spikeADBE

    Adobe Inc. search volume spiked +75 pts - unusual interest

commodity (6)

  • highcommodity_moveOIL

    Oil -6.16% - significant selloff

  • mediumcommodity_moveOIL

    Oil +2.78% - significant rally

  • mediumcommodity_moveOIL

    Oil -3.16% - significant selloff

  • mediumcommodity_moveGOLD

    Gold +1.56% - significant rally

  • mediumcommodity_moveOIL

    Oil -2.04% - significant selloff

  • mediumcommodity_moveGOLD

    Gold +1.29% - significant rally

macro (2)

  • mediumshipping_spikeSHIPPING

    baltic_dry shipping +5.6% - potential inflation signal

  • mediumNFCI_RELIEFMARKET

    Financial conditions loosening - NFCI at -0.51, liquidity supportive